KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Goodwill (2016 - 2019)

Arbutus Biopharma (ABUS) has disclosed Goodwill for 5 consecutive years, with $22.5 million as the latest value for Q2 2019.

  • Quarterly Goodwill changed 0.0% to $22.5 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $22.5 million through Jun 2019, changed 0.0% year-over-year, with the annual reading at $22.5 million for FY2018, 7.77% down from the prior year.
  • Goodwill hit $22.5 million in Q2 2019 for Arbutus Biopharma, roughly flat from $22.5 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $162.5 million in Q4 2015 to a low of $22.5 million in Q2 2018.
  • Historically, Goodwill has averaged $76.5 million across 5 years, with a median of $24.4 million in 2016.
  • Biggest YoY gain for Goodwill was 4.27% in 2016; the steepest drop was 85.01% in 2016.
  • Year by year, Goodwill stood at $162.5 million in 2015, then crashed by 85.01% to $24.4 million in 2016, then changed by 0.0% to $24.4 million in 2017, then fell by 7.77% to $22.5 million in 2018, then changed by 0.0% to $22.5 million in 2019.
  • Business Quant data shows Goodwill for ABUS at $22.5 million in Q2 2019, $22.5 million in Q1 2019, and $22.5 million in Q4 2018.